Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02588170
Brief Title: Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

First Submitted : October 26, 2015
First Submitted that Met QC Criteria : October 26, 2015
First Posted : October 27, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : August 6, 2019
Last Update Posted : August 7, 2019